Drugs / Amniotic Fluid Allograft
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04537026 | Jun 2021 → Jul 2025 | lumbar spinal stenosis | University of Utah | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Amniotic Fluid Allograft | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04537026 ↗ |
| Modality | Other / unclassified | “hAF is a promising new biologic treatment with neuro-protective and regenerative properties.” NCT04537026 ↗ |
| Route | Other | “Amniotic Fluid Allograft will be mixed with sterile water and injected using transforaminal approach” NCT04537026 ↗ |